Business Wire Feed
YMCA FINAO Wellness Café Ignite 2026 Conference Press Release
SEATTLE--(BUSINESS WIRE)--#AI--FINAO SPV Inc. (a venture between FINAO® and Rubix Network) has announced it is working with the YMCA to build The YMCA Wellness Café™, a HIPAA compliant wellness chain that will serve the global more...
Firstsource Named a Leader by Everest Group and NelsonHall in 2026 Healthcare Payer Assessments
Dual recognition highlights platform-led, AI-powered approach to transforming healthcare payer operationsMUMBAI, India--(BUSINESS WIRE)--Firstsource Solutions Limited (NSE:FSL, BSE:532809), an RP-Sanjiv Goenka Group company, has been named a Leader in Everest Group Healthcare Payer Intelligent Operations PEAK more...
Office Ally Acquires Jopari Solutions Inc. to Expand Clearinghouse Network and End-to-End Electronic Transaction Processing
Strategic acquisition adds leading Property & Casualty clearinghouse capabilities and payer-to-provider payment infrastructure to the Office Ally platformNASHVILLE, Tenn.--(BUSINESS WIRE)--Office Ally, a leading provider of healthcare technology clearinghouse and software solutions to a national network more...
eClinicalWorks and healow Genie Assist Estrella ENT in Achieving 70% Call Automation and Improving Front Office Efficiency
The AI-powered contact center solution helps the practice handle calls 24/7WESTBOROUGH, Mass.--(BUSINESS WIRE)--#AI--eClinicalWorks®, one of the largest ambulatory cloud EHRs, today announced that Estrella Ear, Nose and Throat, a high-volume ENT practice managing more than more...
Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program to Make Novel Presbyopia Therapy More Accessible and Affordable
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Tenpoint Therapeutics, a leading ophthalmic manufacturer, and PHIL Inc., an all-in-one digital hub and Direct-to-Patient platform, today announced the launch of a Direct-to-Patient (DTP) cash program for YUVEZZI™, the first and only dual-agent more...
Black Book Recognizes Innovaccer as a 2026 Leader in AI-Powered Revenue Cycle Autonomy and Population Health Data Activation
Innovaccer Ranked #1 in AI-Powered Revenue Cycle Autonomy and PHM by Black Book Research, Outpacing 30-Vendor Field in 2026 Buyer-Led EvaluationSAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, today announced that it has been more...
Planet DDS Expands Clinical Voice+ Suite with AI Voice Restorative Charting
Following AI Voice Perio, voice-driven charting expands to restorative exams, enabling single-provider clinical documentation in DenticonIRVINE, Calif.--(BUSINESS WIRE)--Planet DDS today announced the launch of AI Voice Restorative Charting, the newest capability in the Clinical Voice+ more...
Pearl and RipeGlobal Partner to Transform Dental Excellence Worldwide Through AI-Powered Education and Clinical Intelligence
Integration provides global dental professionals with hands-on education and resources to effectively implement AI, elevate patient care, and optimize practice performanceLOS ANGELES--(BUSINESS WIRE)--#ArtificialIntelligence--Pearl, the global leader in dental AI solutions, and RipeGlobal, the internationally recognized more...
Momentous Funds the Future of Female Performance Research With Collective X Health
The partnership launches the Collective X Health Research Grant Program as the next chapter of Momentous' Change the Ratio commitment, a direct investment in closing the gender gap in performance sciencePARK CITY, Utah--(BUSINESS WIRE)--#ChangeTheRatio--Momentous, a more...
QT Imaging CEO Discusses the Importance of Early Breast Cancer Detection at the Shiftmakers’ Panel and Gala
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that CEO Dr. Raluca Dinu more...
Iterative Health and US Heart & Vascular Enter Strategic Partnership to Advance Community-Based Cardiovascular Research
CAMBRIDGE, Mass. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Iterative Health, a healthcare technology and services company powering the acceleration of clinical research, and US Heart & Vascular (USHV), the nation’s leading provider of support services to cardiovascular physician more...
PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, notes that its Founded Entity, Seaport Therapeutics, today more...
IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl) improves PFS in early liver cancer
IMFINZI plus IMJUDO combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolization-eligible unresectable liver cancer in EMERALD-3 Phase III trial IMFINZI plus IMJUDO combined with lenvatinib more...
WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians
WELL Health and AliveCor have partnered to bring rapid, cardiologist-reviewed ECG services to patients across Canada through the Kardia platform. Under this partnership, WELL Health’s Canadian-registered cardiologists are integrated directly into AliveCor’s AI-powered Kardia platform, more...
Merck Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 (Tiespectus), an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular Degeneration
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of a pivotal Phase 2b/3 trial evaluating MK-8748 (also known as Tiespectus, EYE201), a novel investigational more...
CanWell Pharma Announces FDA Clearance of the IND for CAN016, a Dual-Payload ADC Targeting HER2, for ADC Pre-Treated Solid Tumors
IND approval from the FDA allows CanWell Pharma to assess the safety, tolerability and pharmacokinetics of CAN016 in a Phase I clinical study CAN016, a novel antibody-drug conjugate (ADC), is expected to overcome the resistance more...
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS ≥1) Platinum-Resistant Recurrent Ovarian Carcinoma Who Have Received One or Two Prior Systemic Treatment Regimens
The KEYTRUDA regimen is the first and only PD-1 inhibitor-based treatment approved in the European Union for these patients Approval supported by data from the Phase 3 KEYNOTE-B96 trial in which the KEYTRUDA regimen demonstrated more...
restor3d Announces Full Commercial Release of the Aeros™ Modular Stem System
The First and Only Modular Stem Ankle System Anteriorly InsertedDURHAM, N.C.--(BUSINESS WIRE)--#3DPrinting--restor3d, a leader in 3D-printed, personalized orthopedic solutions, today announced the full commercial availability of the Aeros™ Modular Stem System, an advancement in stemmed more...
EoS Fitness Crowns 2026 Submit Your Fit Winners
The national gym brand recognizes three winners for their inspiring and transformative fitness storiesDALLAS--(BUSINESS WIRE)--EoS Fitness has announced its 2026 winners for the company’s annual Submit Your Fit competition, a nationwide initiative that celebrates the more...
Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone)
Integration Fully Operational on Day One to Ensure Continuity of Care for the ALS Community With More than 100 Team Members Joining Shionogi from Tanabe Pharma America Acquisition Establishes a Strong Commercial Platform in Rare more...
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer Cases Colorectal Cancer Has Become the Leading Cause of Cancer-related Death in Adults Under Age 50 more...
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy
- Collaboration with Amgen to explore the clinical potential of Zai Lab’s DLL3-targeting ADC, zocilurtatug pelitecan, in combination with Amgen’s IMDELLTRA® - Amgen to sponsor and lead global Phase 1b study; Zai Lab to retain more...
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the location of the variant more...
Children’s Hospital Los Angeles Celebrates 125 Years: From One Doctor on Horseback to Global Pediatric Leader
Top 10 pediatric hospital honors a legacy of innovation, compassion, and breakthroughs shaping the future of pediatric medicineLOS ANGELES--(BUSINESS WIRE)--Children’s Hospital Los Angeles (CHLA) is marking its 125th anniversary, celebrating more than a century of more...
Herbalife to Announce First Quarter 2026 Results on May 6
LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, will release its first quarter 2026 financial results after the close of trading on the NYSE on Wednesday, May 6, more...